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LU Shuli1 2,FENG Yan1*,GAO Jie1,JIN Xianggong1,WANG Yixin1,CHEN Keji3
【Abstract】As a traditional Chinese medicine,Panax notoginseng has a significant effect in the treatment of
cardiovascular diseases due to its effect of promoting blood circulation and removing blood stasis.With the
improvement of modern extraction technology,Panax notoginseng extract greatly improves its efficacy.In this
paper,the mechanism of action,clinical effect and possible adverse reactions of Panax notoginseng extract(the main
component of Panax notoginseng saponins,PNS)in the treatment of cardiovascular diseases(coronary heart
disease,hypertension,heart failure,arrhythmia)at home and abroad in recent years were sorted out,and the relevant
literature was analyzed,summarized and summarized.It is concluded that PNS and its effective components have
definite curative effect on cardiovascular disease,especially in coronary heart disease,hypertension,heart
failure,arrhythmia or multiple diseases coexisting,Panax notoginseng extract PNS can play a single drug and play a
variety of pharmacodynamic effects,at the same time, reduce the economic and mental pressure of patients,and
improve the risk of cardiovascular disease quality of life.
【Key words】 Panax notoginseng；Panax notoginseng saponins；Sanchinoside；Cardiovascular diseases；
Cardiovascular agents（TCD）
With the gradual improvement of residents’quality of life and the increasingly bad living habits,the prevalence
and mortality rate of cardiovascular disease are increasing and tend to be younger. At present,cardiovascular disease
is the disease type with the highest mortality rate in China.The number of deaths caused by cardiovascular disease
has exceeded 40% of the total number of deaths from all diseases,which is higher than cancer and another
diseases[1].It brings more and more serious economic burden on society,and has developed into a more serious public
health problem in China.Therefore,the treatment of cardiovascular disease can’t be ignored at this stage.
The advantages of traditional Chinese medicine in improving cardiovascular disease,cardiac function and
quality of life have been recognized by many guidelines.Panax notoginseng is the dry roots and rhizomes of Panax
notoginseng (Burk.)F.H.Chen,it has been widely used and has a long history in China.As early as the Ming
Dynasty,there was a record of"Panax notoginseng"in the wonderful recipe for falling losses (compiled by Yiyuan
Zhenren).In the compendium of Materia Medica (Li Shizhen of Ming Dynasty),the great work of Materia Medica
recorded the form and smell of Panax notoginseng in detail for the first time.It’s pointed out that Panax notoginseng
has the functions of"hemostasis,dispersing blood and relieving pain",and the dual regulating functions of hemostasis
and hemolysis.The saponins in the active extract are the components of promoting blood circulation and removing
blood stasis,and Panax notoginseng saponins(PNS) is the most important part in the extract,therein ginsenosides (Rg1,
Rb1, Rd, Re) and notoginseng saponin R1 are higher [2-3],what have obvious intervention effect on the treatment of
————
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cardiovascular disease[4].There are many preparations with PNS as the main component in clinic.Currently,the drugs
what have used in the treatment of cardiovascular diseases include Xuesaitong injection powder,Xueshuantong
lyophilized
powder,Luotai
powder
injection,Xueshuantong
injection,Lulutong
injection,Xuesaitong
tablets,Xuesaitong capsules,Xuesaitong granules,Xuesaitong dropping pills,etc[5].This article summarizes the
mechanism and clinical application of Panax notoginseng saponins PNS in various cardiovascular diseases.
1 Coronary heart disease
Coronary heart disease is a disease with high incidence and mortality rate in China.It includes chronic
myocardial ischemia syndrome(stable angina pectoris,ischemic cardiomyopathy,occult coronary heart
disease,etc)and acute coronary syndrome[ACS,unstable angina(UA),non-ST-segment elevation myocardial
infarction(NSTEMI)and ST segment elevation myocardial infarction(STEMI)].
1.1 Protect cardiomyocytes and inhibit inflammatory reaction ACS is a group of clinical syndromes based on
the pathological basis of myocardial ischemia caused by coronary atherosclerotic plaque rupture and coronary artery
occlusion.Liu et al.[6] applied PNS to the in vitro model of ischemia H9c2 cells and in vivo model of SD rats with
ligation of left anterior descending branch.The experiment proved that PNS can activate PI3K / Akt signaling
pathway,which had protective effect on myocardial cell apoptosis induced by ischemia.Another research has found
that notoginseng saponin R1 can inhibit inflammatory reaction by inhibiting oxidative stress and reducing the
production of inflammatory cytokines[7].Qi Hong et al.[8] researched the application of Xueshuantong powder in
the treatment of unstable angina pectoris on the basis of anticoagulation,lipid-lowering and another basic
treatments,which was helpful to stabilize coronary atherosclerotic plaque,improve angina symptoms and ECG
changes,improve serum nitric oxide(NO)level, reduce high-sensitivity C-reactive protein(HS CRP)and
fibrinogen(FIB)levels,and then improve the clinical efficacy.
Percutaneous coronary intervention(PCI)is the treatment of ACS by rapid recovery of coronary blood
supply.However,patients with ACS are in hypercoagulable state and operation can induce and aggravate coronary
artery inflammation and destroy vascular intima,so no reflow after operation and restenosis after repair may
occur[9].Fengguanpeng et al.[10] showed that thrombus aspiration combined with intraoperative coronary injection
of Xuesaitong injection in the treatment of acute STEMI patients can significantly improve the coronary blood flow
and accelerate the recovery of cardiac microcirculation after PCI.In addition,Luo Jianhua et al.[11]suggested that oral
trimetazidine tablets combined with Xueshuantong injection can effectively reduce the levels of serum C-reactive
protein (CRP),interleukin-6(IL-6)and tumor necrosis factor(TNF-α)in elderly patients with coronary heart disease
after PCI,and the curative effect was significant.All above the studies showed that Xueshuantong injection can
improve the recanalization rate of PCI vessels, timely rescue and reduce myocardial cell necrosis.
Within 20-30 minutes after coronary artery occlusion in ACS patients,a small part of myocardial cells supplied
by this coronary artery began to degenerate and necrosis;Within 1-2 hours,most of the myocardial cells showed
coagulative necrosis,myocardial interstitial congestion and edema.At the same time,there will be inflammatory
reaction and inflammatory cell infiltration in the surrounding tissue.PNS can improve cardiomyocyte necrosis in
hypoxia,weaken the inflammatory,and then reduce the infarct size and protect myocardial cells.In the above clinical
studies,whether PNS was used in patients without PCI but only routine treatment,or in patients during and after
PCI,the clinical manifestations and related inflammatory indexes of patients with coronary heart disease were
significantly improved,suggesting the effectiveness of PNS clinical treatment.
1.2 Antiplatelet aggregation,enhance the antiplatelet effect of aspirin Atherosclerotic unstable plaque rupture or
erosion brings about coronary thrombosis,which is considered to be the main pathological basis of most ACS,and
platelet aggregation is the key link of pathological thrombosis.A double-blind, double-dummy, randomized controlled
clinical study using PNS and aspirin confirmed that PNS can effectively reduce platelet aggregation rate and platelet
adhesion in vitro;The inhibition of PNS on platelet CD62P and GPⅡB/Ⅲa was better than aspirin[12].Another related
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studies have found that,PNS can enhance the antiplatelet effect of aspirin and reduce the platelet aggregation rate in
the experiment of observing the changes of platelet activity and gastric mucosal damage caused by PNS and aspirin
in the rat model of acute myocardial infarction.The mechanism may be related to PNS regulating of cyclooxygenase
1 of platelet AA pathway (COX-1) and CYP pathway metabolism,which can alleviate the damage of aspirin to gastric
mucosaimprove gastrointestinal symptoms, and increase the contents of serum motilin and gastrin [13].Liu
Changqing[14]found that the levels of main platelet activation markers (CD62P, PAC-1) and platelet parameters
(mean platelet volume, platelet-large cell rate) in patients with acute myocardial infarction treated with Xueshuantong
injection after PCI were significantly decreased, indicating that PNS can inhibit platelet activation, reduce platelet
volume and weaken platelet hyperreactivity to play the role of anti platelet aggregation.Yan Xiaoyan et al.[15]showed
that PNS combined with aspirin had a more significant reduction of platelet aggregation function than aspirin or PNS
alone in the treatment of elderly patients with coronary heart disease.
Antiplatelet therapy is the basis for the treatment of coronary heart disease,and aspirin is one of the most
common antiplatelet drugs in the treatment of coronary atherosclerosis.However,aspirin can lead to gastrointestinal
injury and aspirin resistance,which will affect the clinical efficacy,safety and medication compliance of aspirin.PNS
can inhibit platelet aggregation by itself.When PNS is combined with aspirin,it can enhance the antiplatelet effect of
aspirin and protect gastric mucosa.Therefore,the application of PNS in thrombotic antiplatelet therapy such as
coronary heart disease can improve the efficacy and safety.
1.3 Reduce blood lipid,inhibit apoptosis of vascular endothelial cells In recent years,most experts believe that
the"endothelial injury response theory"is the pathogenesis of coronary heart disease. Judging the various major risk
factors of coronary heart disease will eventually damage the artery intima.Wang et al.[16]found that N-PNS improved
by distillation showed good activity in improving hyperlipidemia,weight loss and inhibiting adipogenesis in obese
mice.N-PNS can inhibit the formation of adipose tissue at the early stage of differentiation.This activity maight be
mediated by promoting the phosphorylation of ampkt172 and down regulating its downstream factors(sterolregulatory element binding protein 1c, stearoyl COA desaturase 1 and fatty acid synthase),adenosine phosphate
activated protein kinase (AMPK) signaling pathway was also involved.In addition,Dong et al.[17]reached the
following conclusion through pharmacological prediction and experimental verification,PNS can inhibit the early
apoptosis of vascular endothelial cells by up regulating the expression of vascular endothelial growth factor AmRNA,thereby reducing the oxidative stress of human umbilical vein endothelial cells induced by hydrogen peroxide,
which confirmed that PNS can directly treat coronary heart disease by treating coronary heart disease target
genes.Wang Ni[18]reported that patients with ACS were treated with Xueshuantong injection after PCI can
significantly improve the levels of total cholesterol (TG),triglyceride (TC),high density lipoprotein cholesterol(HDLC),low density lipoprotein cholesterol(LDL-C),endothelin(ET),nitric oxide(NO)and plasma von willebrand factor
(vWF),which indicates that Xueshuantong is effective in controlling blood lipid level and improving endothelial
function Significant.
Hyperlipidemia can lead to vascular endothelial damage,shedding,and then produce thrombosis and block the
artery,resulting in arterial embolism.Coronary atherosclerosis is the main cause of coronary heart disease,so lipidlowering therapy plays an important role in the acute stage and secondary prevention of coronary heart disease.PNS
can reduce the blood lipid and blood viscosity,inhibit the apoptosis of vascular endothelial cells,thereby reducing
coronary atherosclerosis. PNS has significant clinical effect in improving the blood lipid index of patients with
coronary heart disease,and its safety and indications are better than traditional lipid-lowering western medicine,which
provides more options for the lipid-lowering treatment of coronary heart disease.
2 Hypertension
According to the results of the"China million people program research project"published on lancet in 2017,the
prevalence rate of hypertension in China is 37.2%,but the control rate is only 5.7%[19].It can induce a variety of
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other types of cardiovascular diseases and cause damage to heart, brain, kidney, retina and another target organs,
which plays an important role in the cause of death of cardiovascular diseases. Therefore,in the process of promoting
the prevention and treatment of cardiovascular disease in China,it is extremely effective to rely on the prevention and
treatment of hypertension.
2.1 Dilate blood vessels,lower blood pressure In the pathogenesis of hypertension, the structural changes and
functional abnormalities of both large and small arteries play an important role.A variety of vasoactive
substances,such as NO and prostacyclin(PGI2),are produced,activated and released by endothelial cells on the inner
surface of large and small vessel walls,which play a role in regulating cardiovascular function.LOH et al.[20]found
that the active extract of Panax notoginsengPN95(mainly 25.9% Rg1 and 13.6% Rb1) was induced by nitric oxidesolubility guanylate cyclase-cyclic guanosine monophosphate (NO-SGC-cGMP)and β2-adrenoceptor pathway.PN95
can also regulate vascular tone by regulating action potential through potassium ion,voltage dependent calcium
channel(VOCC)and inositol triphosphate receptor(IP3R).In addition,Yang et al.[21]proved that PNS can induce the
expression of nitric oxide synthase (iNOS) and increase the production of no through long non coding RNA
ak094457,thus promoting endothelium-dependent vasodilation,inhibiting vasoconstriction,and finally achieving the
effect of lowering blood pressure.Yuan Wei[22]showed that Fufang Xueshuantong capsule had significant clinical
effect in the treatment of essential hypertension,and can effectively reduce the levels of NO and ET.The control of
blood pressure is an important link in the treatment of cardiovascular disease.PNS can relax blood vessels and reduce
blood pressure by influencing the expression of various vasoconstrictors,regulating vascular action potential and
inhibiting the structural and functional changes of large and small arteries.Long term clinical application of PNS has
significant antihypertensive effect on essential hypertension.
2.2 Improve the microcirculation of arteriole blood flow
Long term exposure to high pressure leads to the
increase of wall/lumen ratio of systemic arterioles and narrowing of inner diameter of lumen.As a result,the
corresponding target organ ischemia occurs, which promotes the formation and further development of
arteriosclerosis and eventually leads to various complications.Lengxue et al.[23]found that ginsenoside Rb1 can
significantly enhance the microcirculation of cardiac surface in the effect of isoproterenol on microcirculation and
blood flow perfusion in rats with acute myocardial ischemia.CHEN Ye et al.[24]showed that Xueshuantong capsule
combined with aspirin in the treatment of patients with hypertensive retinopathy can significantly improve the ocular
arterial pressure and hemodynamic indexes of central retinal artery,and improve the clinical efficacy.Li Gang
Tie[25]found that Xueshuantong injection combined with benazepril hydrochloride has better clinical efficacy in the
treatment of patients with hypertensive renal damage,and can significantly reduce the level of urinary microalbumin.
Hypertension related complications involve heart,brain,kidney,retina and other organs.PNS can not only
improve the stimulation of small and small vessels by reducing blood pressure,but also prevent complications by
improving microcirculation of arterioles.Therefore,PNS is worthy of popularization and application in hypertension.
3 Heart failure
Heart failure is regarded as the end stage of a variety of cardiovascular diseases. With the increasing aging of
our population,the prevalence of heart failure is increasing.Because of its high incidence rate,high mortality rate and
high treatment cost,it has gradually become the main public health problem in the world.Its main clinical value is to
maintain the structure and function of myocardial cells,improve myocardial remodeling and protect myocardial cells.
Myocardial remodeling is the pathophysiological basis of the continuous progress of chronic heart
failure.Myocardial remodeling refers to the changes of cell structure and cell function caused by the corresponding
molecular biological changes and gene mutation in the cardiac muscle cells in the mechanism of nerve humoral
compensation, which is manifested in the decrease of myocardial quantity and increase of myocardial
fibers[26].Related studies have applied different doses of PNS to rat models of heart failure.The experimental results
show that PNs can not only enhance the diastolic function of ventricular contractile muscle,but also reduce the content
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of serum brain natriuretic peptide and angiotensin II,so as to maintain the structure and function of myocardial cells
and effectively prevent myocardial remodeling[27].In addition, SHAO et al.[28]found that in the study of heart failure
model mice,ginsenoside Rb3 has protective effect on reactive oxygen species(ROS)production induced by
OGD/R,can improve ROS induced energy metabolism disorder,promote the expression of RXRα and SIRT3,thus
increase intracellular ATP level,maintain mitochondrial function and promote energy metabolism,and has good
protective effect on inactive cardiomyocytes.Studies have shown that Xueshuantong injection combined with western
medicine has a significant effect on heart failure,which can effectively reduce left ventricular ejection fraction (LVEF)
and N-terminal pro brain natriuretic peptide (NT-proBNP)[29].The decrease of LVEF indicates the improvement of
left ventricular structural remodeling,and the decrease of NT proBNP can reflect the repair of myocardial cell damage.
As a progressive disease,heart failure needs long-term and effective management and treatment.The mechanism
of PNS in the treatment of heart failure may be to maintain the structure and function of myocardial cells,improve
myocardial remodeling and protect the function of myocardial cells.Coronary heart disease and hypertension are the
causes and causes of heart failure.Therefore,PNS can play a synergistic role in the treatment of conventional anti
heart failure,which can not only effectively control the symptoms of heart failure,but also delay the progress of the
course of disease,reverse myocardial remodeling,and improve the quality of life of patients.
4 Arrhythmia
Arrhythmia refers to the abnormal frequency,rhythm,origin,conduction velocity or activation sequence of
cardiac impulses,which is often manifested as palpitation.At present,atrial fibrillation accounts for a high proportion
in the types of arrhythmia diseases,and it is expected to further accelerate the growth.
Atrial electrical remodeling and structural remodeling are the main known pathogenesis of atrial fibrillation,and
atrial structural remodeling in the form of fibrosis is an important pathophysiological basis for the generation and
development of atrioventricular fibrillation.Therefore,inhibiting atrial fibrosis and intervening in the process of atrial
remodeling can be used as an entry point for the treatment of atrial fibrillation[30].Kang Lingling et al.[31]found that
Notoginsenoside R1 may inhibit the process of myocardial fibrosis and play an important role in the prevention and
treatment of atrial fibrillation by inhibiting the expression of ICAM-1 and TNF-α,down regulating the expression of
MMP-2 and up regulating the expression of TIMP-2.In addition,studies on the assessment of ventricular arrhythmia
in ACS rats have found that,Danqi soft capsule(including Salvia miltiorrhiza and Panax notoginseng)can regulate
interstitial fibrosis,connexin 43(Cx43)expression and cardiomyocyte hypertrophy in peripheral infarct
zone(IBZ)through transforming growth factor-β1 (TGF-β1)/Smad3 pathway,inhibit left ventricular remodeling and
reduce the susceptibility of tachyarrhythmia after myocardial infarction.So as to significantly reduce the induction
rate and score of arrhythmia[32].Many studies have shown that PNS combined with amiodarone can significantly
reduce the recurrence of paroxysmal atrial fibrillation compared with amiodarone alone,and can effectively reduce
the levels of P wave dispersion(Pd),hs-CRP,left atrial diameter(LAD)and cardiac anchor repeat protein (CARP)[3334].
Absolute arrhythmia is a typical manifestation of atrial fibrillation.The above clinical studies can prove that PNS
can effectively control abnormal rhythm in patients with paroxysmal atrial fibrillation.The decrease of inflammatory
indexes and atrial diameter may be related to the mechanism of PNS inhibiting myocarditis and fibrosis.At present,the
clinical research of PNS in arrhythmia is lack of research on other disease types besides atrial fibrillation.Although
the pathogenesis of various arrhythmias is not completely the same,but it will cause the corresponding inflammatory
reaction.We do not know whether the application of PNS has the same effect,so we need to carry out further research.
5 Possible adverse reactions of Panax notoginseng extract
With the application of Panax notoginseng extract in clinical application, the adverse reactions of notoginseng
extract are reported more and more,and its safety has been paid more and more attention.At present,it is believed that
the causes of adverse reactions of Panax notoginseng extract include:(1)The components of Panax notoginseng
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extract are complex,containing a variety of saponin active substances,trace elements and polysaccharides;(2)There
are many kinds of Panax notoginseng extract drugs,and the proportion of different kinds of components is
different,and the extraction process and preparation process of effective components are different;(3)Panax
notoginseng extract directly contains saponin active substances Many kinds of active substances,when combined
with other drugs,can cause direct damage to the body due to the excessive dosage of the same pharmacological
components;(4)Unknown components and impurities in Panax notoginseng extract may directly cause anaphylactoid
reaction in the human body,or it may have antagonistic effect when combined with other drugs;(5)Patients' own
physical differences and medication status,so as to prevent allergic reaction And the route of administration is
different.
It is generally believed that anaphylactoid reaction is not mediated by IgE,and its occurrence may be related to
the direct stimulation of mast cells to release histamine and other mediators[35].Li Liming et al.[36]directly
stimulated RBL-2H3 cells with Xuesaitong injection,which could induce different degrees of cell degranulation and
release histamine and β-aminohexosidase.Cell degranulation could also be observed under toluidine blue and
transmission electron microscope,and there was a dose-dependent relationship,suggesting that Xuesaitong injection
has potential anaphylactoid reaction.
Huang Aiqun[37]through analyzing the clinical data of 80 patients with PNS adverse reactions,it was found that
the incidence of adverse reactions in women over 60 years old was higher than that of men;The number of patients
with adverse reactions in the first drug use was more than 30 minutes after the first drug use patients with more than
min and repeated medication will cause serious adverse reactions;Adverse reactions can involve skin(drug
rash),digestive system(nausea,vomiting),respiratory system(chest tightness,throat foreign body sensation,nasal
congestion,cough),nervous system(dizziness,fatigue, tongue paralysis),which can cause allergic shock,among which,
skin mucosa injury is the most common,the second is digestive system.
At present,the majority of Panax notoginseng extract preparations are Chinese patent medicines.According to
the possible adverse reactions of Panax notoginseng extract,it is suggested that the drug types should be reasonably
selected in clinical application,and the type and quantity should be carefully selected when combined with other
drugs.First,it is clear that Chinese patent medicine is not without side effects and can be taken at will,and the dosage
of the Chinese patent medicine depends on the condition.Before clinical application,it is necessary to consult a
traditional Chinese medicine doctor or pharmacist,collect the patient's history and drug allergy history in detail,and
apply the theory of traditional Chinese medicine to identify whether it is the indication for use,properly grasp the
dosage,strictly abide by the contraindications during medication,properly store the proprietary Chinese medicine and
the expiration date of the drug,so as to ensure the rational,safe and effective use of drugs.
6 Summary
According to the relevant data of《China cardiovascular disease report 2018》,the total number of cardiovascular
patients in China has exceeded 290 million,including 11 million patients with coronary heart disease,245 million
patients with hypertension and 4.5 million patients with heart failure[1],and the total prevalence of atrial fibrillation
in China has reached 0.77%[38].The above data shows that the prevalence of cardiovascular disease in China is not
optimistic.In the treatment of cardiovascular disease,western medicine and surgery can play a better clinical effect,but
it can produce relatively serious adverse reactions and postoperative complications,causing great trouble to clinical
treatment and patients.In contrast,traditional Chinese medicine treatment is safe and safe as a traditional treatment
method in China,and has a good development trend.Panax notoginseng extract has been regarded as a common drug
for cardiovascular disease.Although PNS,the most important extract,has many advantages,such as multiple
channels,multiple targets and relatively few adverse reactions,it has a relatively mild effect,relatively slow starting
time compared with western medicine,and is not used alone in clinical practice.It is often used in combination with
western medicine to increase the therapeutic effect.
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In conclusion,Panax notoginseng is an important and effective traditional Chinese medicine in the prevention
and treatment of cardiovascular disease.Although the incidence of each stage of coronary heart disease,hypertension
and heart failure is not completely the same,but most of them are related and secondary.The basic research of PNS
of Panax notoginseng extract corresponds to the pathogenesis of the above diseases.A number of clinical studies have
confirmed its clinical efficacy,and the drug safety and scope of application are more advantageous than western
medicine.Panax notoginseng extract is widely used in the treatment of coronary heart disease, hypertension and heart
failure and the clinical value of PNS should be recommended.PNS extract of Panax notoginseng in the treatment of
arrhythmia,the current clinical studies are mostly in atrial fibrillation,although there is a certain curative effect,but
specifically in the control of atrial fibrillation attack and then cause adverse reactions,or only in the atrial fibrillation
attack to give relevant specific treatment can make patients more benefit,there is no high quality clinical research to
prove.For the possible adverse reactions of Panax notoginseng extract,drug eruption is the most common
manifestation,which needs more observation in clinical application.
At present,the medical environment attaches importance to the multiple feelings of patients in
physical,psychological and social aspects.Reducing the types of drugs and the times of taking drugs can not only
reduce the economic pressure of patients,but also reduce the mental pressure brought by taking drugs and diseases,so
as to improve the quality of life of patients.Cardiovascular diseases are mostly multi disease,while PNS can be used
as a single drug and produce multiple efficacy results,which makes patients benefit more.However,the number of
high-quality studies on Panax notoginseng extract in cardiovascular disease is limited,and the foreign literature is
less.The improvement of cardiovascular clinical symptoms,reduction of cardiovascular adverse events,and clinical
application safety of Panax notoginseng extract still need to be further confirmed by multi center,large sample,and
higher quality studies,and other mechanisms of its effect on cardiovascular disease still need to be further explored.
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